CordenPharma Signs Life Science Lease in Greater Denver

2300 55th St. Image courtesy of CBRE

CordenPharma, a full-service Contract Development & Manufacturing Organization, has signed a lease to occupy 61,117 square feet at 2300 55th St., a life science property in Boulder, Colo. CBRE’s Blake Harris brokered the lease on behalf of the landlord, TriTower Financial Group.

TriTower purchased the building from Trimble for $21 million in 2021, according to CommercialEdge data. FirstBank provided a $19.4 million acquisition loan, the same source shows.

Completed in 1996 and recently renovated, the property incorporates advanced technology features, providing tech-enabled meeting rooms, high-end office space and modern laboratory space. Amenities include a fitness center, a passenger elevator, controlled access and approximately 180 parking spaces.

CordenPharma has other facilities in the site’s proximity, the lease at 2300 55th representing an expansion of the company’s operations in the area. The firm will use the life science building for engineering, research and development operations.

Located in Denver’s Boulder submarket, the facility is close to an abundance of dining options, retail centers and green areas. Boulder Municipal Airport and Valmont City Park are within 1.5 miles from the property.

The vacancy for lab and good manufacturing practice space in Boulder has reached 4.2 percent at the end of the first quarter of 2023, according to CBRE. The brokerage company has recently represented IDEAYA Biosciences in a 44,000-square-foot lease transaction at 5000 Shoreline Court in South San Francisco.